Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 4/20 | 0.64 |
| ▸ | LMNA | P02545 | 4/20 | 0.64 |
| ▸ | MEN1 | O00255 | 3/20 | 0.64 |
| ▸ | HTT | P42858 | 3/20 | 0.64 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.64 |
| ▸ | MAPT | P10636 | 2/20 | 0.64 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.64 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.64 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.64 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.64 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.64 |
| ▸ | HTR2B | P41595 | 1/20 | 0.64 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.64 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.64 |
| ▸ | PARP1 | P09874 | 1/20 | 0.55 |
| ▸ | TBXAS1 | P24557 | 1/20 | 0.54 |
| ▸ | CTNNB1 | P35222 | 1/20 | 0.51 |
| ▸ | HTR1A | P08908 | 1/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.50 |
| ▸ | IRAK4 | Q9NWZ3 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11547493 | 0.87 | KDM4E (0.66) | KMT2ALMNAMEN1HTTKDM4E | |
| SCHEMBL1894429 | 0.87 | KMT2A (0.66) | KMT2ALMNAMEN1HTTKDM4E | |
| SCHEMBL7114649 | 0.86 | LMNA (0.69) | KMT2ALMNAMEN1HTTKDM4E | |
| Hydrochloric Acid SCHEMBL326327 | 0.86 | KDM4E (0.64) | KMT2ALMNAMEN1HTTKDM4E | |
| SCHEMBL3825061 | 0.85 | KDM4E (0.63) | KMT2ALMNAMEN1HTTKDM4E | |
| SCHEMBL10456764 | 0.85 | HTR2B (0.48) | KMT2ALMNAMEN1HTTKDM4E | |
| SCHEMBL18700963 | 0.84 | ALDH1A1 (0.71) | KMT2ALMNAMEN1HTTKDM4E | |
| Hydrochloric Acid SCHEMBL28285783 | 0.84 | KDM4E (0.61) | KMT2ALMNAMEN1HTTKDM4E | |
| SCHEMBL31133329 | 0.84 | ALDH1A1 (0.71) | KMT2ALMNAMEN1HTTKDM4E | |
| SCHEMBL15525445 | 0.83 | MAPT (0.60) | KMT2ALMNAMEN1HTTKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8193360-B2 | Radiolabelled fluorobenzamide analogues, their synthesis and use in diagnostic imaging | WASHINGTON UNIVERSITY (US) | 2012-06-05 | — | — | US | disclosed |
| US-20110230662-A1 | RADIOLABELLED FLUOROBENZAMIDE ANALOGUES, THEIR SYNTHESIS AND USE IN DIAGNOSTIC IMAGING | WASHINGTON UNIVERSITY (US) | 2011-09-22 | — | — | US | disclosed |
| US-7947838-B2 | Radiolabelled benzamide analogues, their synthesis and use in diagnostic imaging | WASHINGTON UNIVERSITY (US) | 2011-05-24 | — | — | US | disclosed |
| US-20100150836-A1 | RADIOLABELLED BENZAMIDE ANALOGUES, THEIR SYNTHESIS AND USE IN DIAGNOSTIC IMAGING | WASHINGTON UNIVERSITY (US) | 2010-06-17 | — | — | US | disclosed |
| EP-2164327-A2 | RADIOLABELLED FLUOROBENZAMIDE ANALOGUES, THEIR SYNTHESIS AND USE IN DIAGNOSTIC IMAGING | WASHINGTON UNIVERSITY (US) | 2010-03-24 | — | — | EP | disclosed |
| US-7659400-B2 | Radiolabelled benzamide analogues, their synthesis and use in diagnostic imaging | WASHINGTON UNIVERSITY (US) | 2010-02-09 | — | — | US | disclosed |
| WO-2009025914-A2 | RADIOLABELLED FLUOROBENZAMIDE ANALOGUES, THEIR SYNTHESIS AND USE IN DIAGNOSTIC IMAGING | WASHINGTON UNIVERSITY (US) | 2009-02-26 | — | — | WO | disclosed |
| US-20080107599-A1 | RADIOLABELLED BENZAMIDE ANALOGUES, THEIR SYNTHESIS AND USE IN DIAGNOSTIC IMAGING | WASHINGTON UNIVERSITY OF ST. LOUIS | 2008-05-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080107599-A1 | RADIOLABELLED BENZAMIDE ANALOGUES, THEIR SYNTHESIS AND USE IN DIAGNOSTIC IMAGING | TMEM97, SIGMAR1, SFN | KMT2A 2552/4885LMNA 3852/4885MEN1 1517/4885 |
| US-20100150836-A1 | RADIOLABELLED BENZAMIDE ANALOGUES, THEIR SYNTHESIS AND USE IN DIAGNOSTIC IMAGING | TMEM97, SIGMAR1, SFN | KMT2A 2552/4885LMNA 3852/4885MEN1 1517/4885 |
| US-20110230662-A1 | RADIOLABELLED FLUOROBENZAMIDE ANALOGUES, THEIR SYNTHESIS AND USE IN DIAGNOSTIC IMAGING | TMEM97, SIGMAR1, SFN | KMT2A 2747/4885LMNA 4243/4885MEN1 1590/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.